MCAS BY PRISM NEURO

Movement control is governed by three distinct neural systems, yet no clinical or performance tool objectively measures each within a single integrated workflow. Existing approaches are subjective or measure movement outcomes without identifying underlying causes. Practitioners can observe impaired movement, but not understand why. Decades of sensorimotor research remained confined to laboratories, inaccessible to frontline use. The challenge was to translate this science into a deployable system: accurate enough for research, portable enough for remote environments, and intuitive for non-specialist operators. It also needed to deliver rapid, meaningful results without reliance on patient history, subjective interpretation, or prior baseline testing.

MCAS distills decades of sensorimotor research into a rapid, modular test sequence. Sensitive enough to reveal hidden deficits arising from the compensatory nature of movement control, the system is portable, easy to operate and gentle on participants. A normative database ensures results are immediately meaningful.The system comprises a precisely fabricated, anodised aluminium hardware device — modular in construction, straightforward to assemble, and lightweight for portability — combined with proprietary testing and analysis software and peripherals including a stand-mounted VR headset. Deliberately low-profile in form and restrained in material choices, MCAS integrates seamlessly across clinical, sporting, and research settings.

MCAS is currently deployed across professional sport and healthcare research. Independent research with the Massachusetts Institute of Technology, University of Canberra, and NSW Institute of Sport has validated its reliability across populations. Published studies demonstrate measurable links between MCAS scores and concussion recovery, athletic performance and long COVID effects. Space research has demonstrated its utility for low-gravity effects. Its portability and ease-of-use enable deployment across gyms, consulting rooms, and remote field sites where complex clinical equipment cannot operate. For practitioners, this provides objective evidence where previously only subjective judgement existed, improving decision-making, reducing risk, and supporting more targeted intervention strategies.

Integrated system architecture, MCAS combines purpose-built hardware, immersive visual testing, and proprietary software into a unified platform designed to standardise assessment and reduce variability across operators, environments, and sessions.World-first multimodal assessment, MCAS is the first system to measure proprioceptive, visual, and vestibular function within a single workflow, replacing multiple instruments, subjective assessment methods, and specialist operators with one integrated platform delivering objective data.Designed for real-world deployment, Rapid (<10 minute) testing, portability, minimal setup, and standardised protocols enable scalable use across elite sport, clinical, research, and remote operational environments. Testing is non-invasive and designed to minimise participant burden and symptom provocation.Modular, considered construction, Precision-machined anodised aluminium components and minimal-part architecture ensure the system remains lightweight, durable, repairable, and straightforward to assemble, transport, and service.Discreet, resolved form, A low-profile aesthetic, refined finishes, and laser-etched detailing enable seamless integration across environments as varied as physiotherapy clinics, elite training facilities, or remote research sites.Complex science, simplified, Decades of sensorimotor research are translated into intuitive, walk-up testing through simplified software workflows, automated analysis, and accessible user interfaces, requiring no specialist training or prior baseline data.Cloud-connected analytics, Secure, real-time insights benchmarked against normative datasets support practical interpretation and longitudinal decision-making.